The SMC has previously accepted zonisamide for restricted use in adults with partial seizures, with or without secondary generalisation. It was restricted to initiation by physicians with appropriate experience in the treatment of epilepsy and should be used principally in patients who have not benefited from treatment with an older anticonvulsant (e.g. carbamazepine; sodium valproate), or for whom these drugs are unsuitable.